Molecular bodyguards against Parkinson's disease
on December 4, 2019 at 7:58 pm
Chaperone proteins in human cells dynamically interact with the protein alpha-Synuclein, which is strongly associated with Parkinson's disease. A disturbed relationship to these 'bodyguards' leads to cell damage and the formation of Lewy bodies typical for Parkinson's disease.
Minimally invasive procedure relieves tremors in Parkinson's patients
on November 26, 2019 at 12:52 pm
A procedure that applies pulses of focused ultrasound to the brain is safe and effective for reducing tremors and improving quality of life in people with essential tremor or Parkinson's disease tremor, according to a new study.
Increased use of antibiotics may predispose to Parkinson's disease
on November 22, 2019 at 4:33 pm
Higher exposure to commonly used oral antibiotics is linked to an increased risk of Parkinson's disease according to a recently published study. The strongest associations were found for broad spectrum antibiotics and those that act against against anaerobic bacteria and fungi. The timing of antibiotic exposure also seemed to matter.
Researchers uncover new molecular drivers of Parkinson's disease
on November 20, 2019 at 12:07 pm
Scientists have uncovered new molecular drivers of Parkinson's disease using a sophisticated statistical technique called multiscale gene network analysis (MGNA). The team was also able to determine how these molecular drivers impact the functions of genes involved in the disease. The results may point to potential new treatments.
Defining a new approach to treating Parkinson's disease
on November 12, 2019 at 4:03 pm
Scientists have identified Cav2.3 as a new target for a promising specific therapy.